✨
AI Summary
- Dr. William Li discusses GLP-1 agonists and their potential to reduce cancer risk.
- Explores how GLP-1 signaling impacts the cellular environment to inhibit cancer growth and metastasis.
- Covers research on GLP-1s' role in lowering cancer incidence and recurrence rates.
Guests on This Episode
WL
William Li
43 podcast appearances